Skip to main content
2025 AABB Annual Meeting Main banner

CBC: The Role of MSC´s in the Development of Regenerative Cell Therapies

AM25-ST-23-L - CBC: The New Frontiers of MSC´s in Regenerative Medicine

Saturday, October 25, 2025
8:15 AM - 9:15 AM  PT
Location: 32

    Program Chair(s)

  • WV

    Wouter Van't Hof, PhD

    Cord Blood Bank Director
    Cleveland Cord Blood Center

    Disclosure information not submitted.

    • Speaker(s)

  • EA

    Ed Ahn, Ph.D (he/him/his)

    Chief Executive Officer & Director
    MEDIPOST, Inc.
    Cambridge, Massachusetts

    Disclosure(s): No financial relationships to disclose

  • SI

    Siliviu Itescu, MBBS, FRACP

    Chief Executive Officer & Managing Director
    Mesoblast

    Disclosure information not submitted.

How can MSC´s, in particular cord tissue derived MSC´s, expand the scope of our sector evolving from a cord blood transplantation focus to a broader cell therapy approach, in other specialties such as pediatrics, endocrinology, neurology, among others.

Learning Objectives:

  • Where do we stand in regenerative cell therapies using MSC's
  • Cord blood-derived MSC's to treat cartilage degeneration
  • Bone Marrow MSC's to reat acute GVHD